<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated on Sat, 31 Jul 2010 14:46:16 -0500 -->
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <atom:link href="http://www.lipid.org/newcommunity/rss_show_blogs.php" rel="self" type="application/rss+xml" />
    <title>My Blogs</title>
    <description>The is all Blogs from lipid.org.</description>
    <language>en-us</language>
    <managingEditor>NLA(pardeep.kapoor@infoproworldwide.com)</managingEditor>
    <webMaster>NLA(pardeep.kapoor@infoproworldwide.com)</webMaster>
    <generator>RSS Feed Generator</generator>
    <item>
      <title>Genetic testing - LDL-R, ApoB mutations & others- uses, reimbursement, value?</title>
      <description><![CDATA[ <p>Does anyone have significant clinical experience with genetic testing for FH with LDL-R or ApoB mutation assays.&amp;nbsp; Several labs offer these DNA studies for definitive diagnosis.&amp;nbsp; It is tantalizing to be certain, but the cost ($1500+) is significant.&amp;nbsp; Also other assays for ApoA2, PON2, ApoC3, ABCA1 etc are available from some labs as a &amp;quot;comprehensive screen for familial early atherosclerosis.&amp;quot;&amp;nbsp; I&amp;#39;d be interested in your non-research justification, if any, for these tests.</p> ]]></description>
      <link>http://www.lipid.org/newcommunity/blogs/entry/Genetic-testing-LDL-R-ApoB-mutations-others-uses-reimbursement-value-</link>
      <pubDate>Fri, 29 Jan 2010 13:36:30 CST </pubDate>
      <author> </author>
      <guid isPermaLink="true">http://www.lipid.org/newcommunity/blogs/entry/Genetic-testing-LDL-R-ApoB-mutations-others-uses-reimbursement-value-</guid>
    </item>
  </channel></rss>